Introduction
Cell division relies upon the assembly of a microtubule-based mitotic spindle apparatus that captures, aligns, and segregates duplicated chromosomes. This construction process requires biochemical signaling to promote microtubule assembly and subsequent structural cues to organize these microtubules into a bipolar array. The major sites for microtubule assembly are the centrosomes, which form the spindle poles, but assembly also occurs near kinetochores. 1 Microtubule assembly is spatially regulated by localized activation of the mitotic kinase, Aurora A. [2] [3] [4] [5] These microtubules are then organized into a bipolar structure through the actions of protein complexes that include molecular motors, such as dyneins and kinesins.
The receptor for hyaluronan-mediated motility (RHAMM) is a microtubule-associated protein that ensures the structural integrity of the mitotic spindle. RHAMM is able to bind microtubules directly at the amino (N) terminus and indirectly at the carbox (C) terminus through a complex with dynein. In this way, RHAMM serves as a structural adaptor that cross links microtubules. [6] [7] [8] RHAMM is also part of a heterodimer docking complex that links dynein to the mitotic spindle, which functions to define spindle orientation during metaphase. 9 Moreover, XRHAMM, the Xenopus ortholog of human RHAMM, focuses anastral spindle microtubules, and this action relies upon a C-terminal basic leucine zipper (bZIP) motif. 10, 11 Thus, to date, RHAMM is known to play key structural roles at the mitotic spindle.
The C-terminal bZIP motif in RHAMM is 70% homologous with the C terminus of Xenopus kinesin-like protein 2 (XKlp2). 6 This domain in XKlp2 is necessary for a complex with dynein and the spindle assembly factor, targeting protein for XKlp2 (TPX2). 12 In both human and Xenopus mitotic cells, RHAMM is a partner protein of TPX2; a ternary complex between these 2 proteins and dynein maintains spindle integrity and promotes spindle pole focusing. 6, 10 TPX2 is also a co-factor for Aurora A and is both sufficient to activate the kinase above basal levels and necessary for optimal kinase activity. 13, 14 As 40-60% of TPX2 is in a complex with RHAMM in human mitotic cells, 7 a regulatory relationship between RHAMM and Aurora A activity has been postulated 10, 11, 15 but not yet been demonstrated. Aurora A promotes microtubule assembly by targeting its substrates to sites of assembly [2] [3] [4] [5] 16, 17 and by protecting these substrates from proteolytic degradation. 15, 18, 19 Aurora A is under regulatory control by multiple factors, 13, [20] [21] [22] but a complex between Indeed, microtubule assembly near to the kinetochores relies on the localized activation of Aurora A by TPX2, which is released from binding partners in response to a gradient of active Ran on the chromosomes. 1, 16, 24, 25 Thus, Aurora A activity is dependent on and limited by TPX2 availability and location, which may be regulated by RHAMM.
Here, we found that RHAMM localized to the centrosomes and near to the kinetochores, and promoted microtubule assembly at these sites. The silencing of RHAMM mislocalized TPX2 and attenuated both the kinetics of mitotic spindle assembly and mitotic microtubule regrowth. As a result, the activity of Aurora A was attenuated, and mitotic spindle length was reduced.
Overall, our findings demonstrate a novel role for RHAMM in the regulation of Aurora A activity and suggest that RHAMM integrates structural and biochemical pathways to ensure proper mitotic spindle assembly and organization.
Results

RHAMM localized to centrosome and non-centrosomal spindle microtubule assembly sites
To query a putative role for RHAMM during spindle assembly, we used immunofluorescence to localize RHAMM in prophase cells and found that it co-localized with a centrosome marker (gamma-tubulin, TUBG1) and decorated mitotic microtubules and spindle poles in cells at later stages of mitosis ( Fig. 1A) (Fig. S1A) . 6 In prophase HeLa cells, we localized RHAMM to discrete foci within the chromosome volumes (Fig. 1A) . Ectopically expressed GFP-RHAMM also localized to punctuate, non-centrosomal sites, which co-localized near to a kinetochore marker (Bub1-related kinase, BubR1) (Fig. 1A) . This localization was more pronounced in the hematopoietic cell line, RPMI-8226 (Fig. 1B, arrows) . We asked whether these foci may be sites for microtubule assembly using a regrowth assay in which microtubules in mitotic cells were depolymerized with nocodazole and allowed to regrow during a recovery phase. As shown at 2 m for recovery, microtubules (β-tubulin, TUBB) were first assembled at centrosomes, demarked by TUBG1 (Fig. 1C) . By 6 min for recovery, mitotic microtubules were assembled at centrosomes as well as non-centrosome sites, which co-localized with BubR1 (Fig. 1C) . In these microtubule-regrowth experiments in mitotic cells, RHAMM localized to both centrosome and non-centrosome sites of microtubule assembly (Fig. 1C) .
RHAMM is required for normal mitotic spindle assembly kinetics and architecture
To query whether RHAMM contributes to microtubule assembly or is simply a passenger microtubule-associated protein at these sites, cells were separately treated with 3 siRNA duplexes that target the untranslated regions (UTRs) of RHAMM mRNA, which enabled us to silence RHAMM and rescue function through transient expression of the wild-type transgene tagged with GFP at the vN-terminus (GFP-RHAMM). With the outlined protocol (Fig. S1B) , endogenous RHAMM mRNA levels were reduced by 40-70% (Fig. S1C) , which translated to a 70-80% reduction in the levels of RHAMM protein (Fig. 1D) . Rescue with GFP-RHAMM resulted in transgene expression at levels that approximated endogenous RHAMM levels (top band is GFP-RHAMM in Fig. 1E ), and we confirmed that GFP-RHAMM localized in a manner that is similar to that of the endogenous protein (Fig. S1D) . Consistent with the previously established role for RHAMM as a structural mitotic spindle protein, the silencing of RHAMM resulted in a significant increase in both the proportion of cells with mitotic spindle defects, such as multipolar spindles and disorganized spindles (Fig. 1F ) and multinucleated cells (Fig. 1G) , which may result through the failure of cell division. Importantly, both of these depletion phenotypes could be rescued through the transient expression of GFP-RHAMM ( Fig. 1F and G) . Moreover, in RHAMMsilenced HeLa cells, we found a significant increase in the proportion of mitotic cells, which suggested that the silencing of RHAMM induced a mitotic arrest and/or delayed mitotic kinetics (Fig. 1H) .
To help distinguish between mitotic arrest and delayed kinetics, living, non-synchronized HeLa cells were followed by timelapse microscopy as they transited through mitosis ( Fig. 2A and  B ; Videos S1-4). We quantified the time necessary for spindle assembly and mitosis completion by tracking the progression of mitotic cells (Fig. 2C) . Spindle assembly duration was defined as the time from the onset of prophase (chromosome condensation) to the onset of metaphase (chromosome alignment), and mitosis duration was measured from the onset of prophase to the end of telophase (disappearance of the midzone spindle). In cells pretreated with scrambled control siRNA, the average duration for spindle assembly was 26 ± 9 min, and these cells completed mitosis in 106 ± 17 min ( Fig. 2C ; Video S1), which are similar kinetics to those of untreated cells (27 ± 13 min and 118 ± 24 min, respectively). Silencing of RHAMM, however, resulted in a significant delay in both the time necessary to assemble a bipolar spindle and the time necessary to complete mitosis (51 ± 17 min and 185 ± 32 min, respectively) ( Fig. 2C ; Videos S2 and 3); indeed, 43% of mitotic cells pretreated with siRNA duplexes targeting RHAMM were unable to complete mitosis during the imaging time, and these cells were excluded from the quantitation of kinetics (Fig. 2C) . Moreover, we found that phenotypically normal mitotic spindles would rotate freely in cells pretreated with siRNA targeting RHAMM (Video S3), consistent with a necessary role for RHAMM in the establishment of mitotic spindle orientation. 9 Mitotic defects that accompanied the silencing of RHAMM were attenuated when GFP-RHAMM was transiently expressed ( Fig. 2B and C; Video S4) , which indicates that defects in spindle assembly, both kinetics and structure, can be assigned to the specific loss of RHAMM.
RHAMM is required for TPX2 localization and stability To dissect the contributions of RHAMM to mitotic spindle assembly, the kinetics of mitotic microtubule regrowth after nocodazole depolymerization were followed in prophase cells that were previously treated with a scrambled control siRNA duplex or with duplexes targeting RHAMM. In comparison to controltreated cells, the silencing of RHAMM delayed the assembly of microtubule asters and the formation of a bipolar spindle following nocodazole washout ( Fig. 3A ; Videos S5 and 6), suggesting that RHAMM may play a role in seeding or establishing microtubule assembly sites. The attenuation of assembly was quantified in fixed cells at 6 min following recovery, when both centrosome and non-centrosomal assembly sites were present in the control-treated cells. Silencing of RHAMM resulted in a significant reduction in the number of microtubule foci assembled at non-centrosomal sites, and rescue with GFP-RHAMM was sufficient to recover non-centrosome microtubule assembly in RHAMM-silenced mitotic cells (Fig. 3B) .
In Xenopus meiotic cell extracts, immunodepletion of XRHAMM prevented TPX2 concentration to DMSO-induced microtubule spindle poles, 10 so we examined whether the silencing of RHAMM in mitotic HeLa cells prevented the localization of TPX2 to sites of microtubule assembly. In RHAMM-silenced mitotic cells, we found significantly fewer TPX2-positive microtubule regrowth sites (Fig. 3C) . Pre-treatment of mitotic cells with nocodazole may dramatically alter microtubule assembly kinetics due, in part, to residual drug. So, we examined the immunolocalization of TPX2 in non-synchronized mitotic HeLa cells and found that TPX2 was lost from spindle poles (i.e., regions of interest identified by TUBG1) in RHAMM-silenced mitotic cells (Fig. 3D) .
In both of the described assays, the abundance of TPX2 appeared reduced by immunofluorescence in RHAMM-silenced cells. To test the possibility that the specific loss of RHAMM altered the stability of TPX2, the abundance of these proteins were determined in lysates from G 2 /M synchronized cell populations, as each gene product is strongly cell cycle regulated. 6, 7, 26 Synchronized populations of RHAMM-silenced cells showed reduced abundance of RHAMM and TPX2, but not the GTP binding protein Ran (Fig. 3E) . Pre-treatment of cells with the proteasome inhibitor MG132 was sufficient to recover the level of TPX2 in RHAMM-silenced cells (Fig. 3E) , which implies that the loss of RHAMM augments proteasome-dependent turnover of TPX2.
We next measured the levels of Aurora A and active, autophosphorylated Aurora A (pAurora A) in these lysates. Like TPX2, the abundance of Aurora A and the levels of pAurora A were reduced in RHAMM-silenced G 2 /M synchronized cell lysates (Fig. 3F) . Proteasome inhibition was sufficient to recover the total level of Aurora A (Fig. 3F) . However, proteasome inhibition did not completely recover pAurora A, which remained attenuated in the presence of the correct levels of total Aurora A and TPX2 (Fig. 3F) . These data support a regulatory role for RHAMM in the activation of Aurora A. The silencing of RHAMM reduced the abundance of TPX2, but even when the abundance of TPX2 was restored through proteasome inhibition, the level of active pAurora A was sub-optimal due to the mislocalization of TPX2.
The C-terminal bZIP of RHAMM binds near the nuclear localization signal of TPX2 to correctly locate TPX2 to sites of microtubule assembly and control spindle length
To better define the RHAMM-TPX2 protein complex and map the domains necessary for this interaction, truncation mutants were constructed for the C-terminus of RHAMM (Fig. 4A) . These variants for GFP-RHAMM were transiently expressed in cells depleted of endogenous RHAMM, and the ability of these variants to co-precipitate TPX2 was tested through immunoprecipitation with antibodies to GFP, or IgG control antibodies. TPX2 was efficiently co-precipitated by RHAMM variants that contained a minimal necessary binding domain of amino acids 623-679 (i.e., full-length, 1-679, and 623-724), which contains the bZIP motif (Fig. 4B) . Indeed, mutation to arginines of the 3 leucines in the motif was sufficient to abolish TPX2 from the precipitates (Fig. 4B) .
Reciprocal studies were performed with transient expression of truncation variants for human TPX2. Since there are essential protein-binding domains in both the N-and C terminus of TPX2, we designed various truncation mutants from wildtype transgene tagged with either mCherry at the N terminus (mCherry-TPX2) or GFP at the C terminus (TPX2-GFP) to map the domains necessary for RHAMM interaction. mCherry-TPX2 and TPX2-GFP truncation mutants were transiently expressed in HeLa cells (Fig. 4C) and immunoprecipitated with antibodies to GFP, antibodies to mCherry, or IgG control antibodies. mCherry-TPX2 (FL) co-precipitated RHAMM and Aurora A, which was included as a positive control (Fig. 4D) . The Klp2-targeting domain (aa 319-783 27 ) was not sufficient to co-precipitate RHAMM (Fig. 4D) . The N terminus of TPX2 (aa 1-319), however, was sufficient, and the deletion of the Aurora A binding domain (aa 1-40 13, 27 ) did not alter the complex formation (Fig. 4D) . Together, these data localize the RHAMMbinding domain in TPX2 to amino acids 40-319, which contain an importin-α binding motif. 28 Compressed mitotic spindles result directly from the loss of TPX2 at the pole, which attenuates kinetochore-mediated microtubule assembly and spindle length. 29, 30 So, we measured TPX2 localization at spindle poles (Fig. 5A) and mitotic spindle length (Fig. 5B) to map the minimal necessary domain in RHAMM for TPX2 targeting and retention. Our observations, and findings by others 9 demonstrate that mitotic spindle orientation is disturbed in RHAMM-silenced cells. Spindle rotation may result in normal length spindles appearing compressed when viewed along the z-axis. To avoid this potential confounding factor, we measured pole-to-pole distance along a plane that is perpendicular to the aligned chromosomes in a 3D image, using TUBG1 as a marker protein for spindle poles.
In RHAMM-silenced cells rescued with GFP-RHAMM (full-length) or GFP-RHAMM(1-679) variants, TPX2 localized to the poles and decorated phenotypically normal mitotic Figure 2 . proper mitotic kinetics and spindle microtubule assembly are dependent on RHAMM expression. (A) Living HeLa cells expressing eGFptubulin and mCherry Histone-H2B were treated with either control siRNA or siRNA duplexes targeting RHAMM and followed through mitosis using timelapse microscopy. Scale bars = 10 μm. (B) HeLa cells were treated with siRNA duplexes targeting RHAMM and rescued with exogenous GFp-RHAMM. Cells were labeled with Hoechst to visualize DNA and followed through mitosis using time-lapse microscopy. Scale bars = 10 μm. (C) the kinetics for mitosis in RHAMM-silenced cells was delayed. expression of exogenous GFp-RHAMM significantly reduced the time to transit through mitosis. Cells that did not complete mitosis during imaging are plotted at 0 min and were not included in the quantitation of mitosis duration. (mean ± s.d., n = 6, *P < 0.05). (Fig. 5A) of typical lengths (Fig. 5B) . However, the expression of GFP-RHAMM(1-623), which lacks the bZIP motif, or GFP-RHAMM(623-724) was not sufficient to correctly localize TPX2, and, consistently, mitotic spindle lengths were significantly compressed when compared with those in control-treated cells or cells expressing full-length or GFP-RHAMM(1-679) variants (Fig. 5B) . Thus, the bZIP motif in RHAMM is required, but is not sufficient, for the correct targeting and retention of TPX2 at spindle poles.
To define the necessary domains in TPX2 that may target RHAMM, reciprocal targeting experiments were performed in HeLa cells treated with shRNA targeting TPX2 (Fig. S2A) . We found that RHAMM remain localized to unfocused spindle poles in TPX2-silenced mitotic cells (Fig. 5C) . However, we observed compressed spindles in TPX2-silenced cells, in a fashion similar to RHAMM-silenced mitotic cells. These compressed phenotypes were rescued only by the expression of full-length mCherry-TPX2 and not by truncation variants (Fig. 5D and E) . Thus, TPX2 is not required for the correct targeting and retention of RHAMM at spindle poles.
RHAMM is required for the temporally and spatially regulated activity of Aurora A A regulatory relationship between RHAMM and Aurora A activity during mitotic spindle assembly is implied from our prior results (Fig. 3F) but not yet demonstrated. Therefore, we designed a series of experiments to examine the effects of RHAMM depletion on the activity of Aurora A. In asynchronous mitotic cells, we measured by immunofluorescence the levels of pAurora A at mitotic spindle poles, as demarked by TUBG1 (Fig. 6A) ; as a control for these studies, mitotic cells were pretreated with an Aurora A-specific small-molecule inhibitor, MLN8237, or vehicle DMSO control (Fig. S2C) . Depletion of RHAMM, or pre-treatment with MLN8237, significantly reduced the levels of pAurora A at spindle poles (Figs. 6A; Fig. S2C ). For kinetic and spatial analysis of Aurora A activity at non-centrosome sites of assembly, we used mitotic microtubule regrowth experiments. First, we measured pAurora A abundance by immunofluorescence at sites for microtubule regrowth following 6 min for recovery. In scrambled siRNA-treated (control) cells, or vehicle-treated cells, non-centrosome sites for assembly were strongly positive for pAurora A (Figs. 6B; Fig. S2D) . Depletion of RHAMM, or pretreatment with MLN8237, reduced pAurora A intensity at these sites ( Figs. 6B; Fig. S2D ).
Non-centrosome sites of assembly following recovery from nocodazole were attenuated with RHAMM depletion, which hindered the measurement of pAurora A at these sites. Thus, we utilized a FRET-based probe for Polo-like kinase 1 (PLK1) activity that is targeted to kinetochores 31 to indirectly measure the spatial and temporal activity of Aurora A. PLK1 is a substrate for Aurora A and depletion of Aurora A by siRNA was sufficient to attenuate PLK1 activity. [32] [33] [34] [35] Following nocodazole washout, PLK1 activity is high in prometaphase cells and resolves with lower phosphorylation at metaphase alignment; the current iteration of the probe 31 tracks these kinase dynamics with an increasing FRET ratio (reflecting a decreasing level of phosphorylated substrate) as the cell progresses towards metaphase (Fig. 6C) . We confirmed that the FRET emission ratio of the sensor was increased in the presence of the PLK1-specific inhibitor, BI2536, within prometaphase cells (Fig. 6D) . In metaphase cells, however, PLK1 inhibition did not further augment the emission ratio, indicating, as expected, a low level of kinase activity within cells at this stage of mitosis (Fig. 6D) . Incubation with the Aurora A-specific inhibitor, MLN8237, was sufficient to augment the emission ratio in prometaphase cells as was the pre-treatment of cells with siRNA to RHAMM, but not scrambled siRNA controls (Fig. 6D) . Together, these data suggest that the loss of RHAMM attenuates Aurora A activity at kinetochores and sites of microtubule assembly in prometaphase cells.
Discussion
Construction of the mitotic spindle is a multi-step process that relies on microtubule assembly at various sites within the cell. RHAMM is a key cell division gene product 36 that provides structural cues to maintain spindle integrity 6, 7 and establish spindle position. 9 A series of papers from work in Xenopus cells suggest that XRHAMM supports anastral microtubule assembly, 10, 11, 37 potentially through regulation of Aurora A activity. These papers attempt to mechanistically bridge the actions of the tumor-suppressive BRCA1-BARD1 complex, which targets RHAMM for degradation, 11, 15 to the oncogenic Aurora A-TPX2 complex during mitotic spindle assembly. However, it is not yet clear whether XRHAMM promotes 10 or prevents 11 TPX2 availability at sites of assembly. Moreover, recent work by Barr and colleagues did not detect RHAMM (aka HMMR) at the Figure 3 (See previous page) . RHAMM is required for spindle microtubule assembly and tpX2 localization and stability. (A) In living HeLa cells expressing GFp-tubulin, microtubule assembly and the formation of a bipolar spindle following nocodazole treatment was disrupted in cells treated with siRNA targeting RHAMM. Scale bars = 10 μm. (B) In mitotic HeLa cells recovering from nocodazole treatment, microtubule assembly at non-centrosomal sites was attenuated in RHAMM-silenced cells, and the expression of GFp-RHAMM was sufficient to re-establish microtubule assembly at these sites. Scale bars = 10 μm. (mean ± s.d., n = 4, *P < 0.05). (C) tpX2 localization to non-centrosomal microtubule assembly sites was abolished in RHAMM-silenced mitotic cells during recovery from nocodazole, and the expression of GFp-RHAMM was sufficient to re-establish microtubule assembly at these sites. Scale bars = 10 μm. (D) tpX2 specific immuno-staining at spindle poles (regions of interest identified by tUBG1) was significantly reduced in cells treated with siRNA targeting RHAMM. Scale bars = 10 μm. (mean ± s.d., n = 3, *P < 0.05). (E) In synchronized early mitotic cells, the levels of RHAMM and tpX2 were reduced in cells pretreated with siRNA targeting RHAMM compared with those treated with scrambled control siRNA. proteasome inhibition (MG132, 15 μM) was sufficient to recover the level of tpX2 in RHAMM-silenced cells. Ran served as a related protein that was unaffected in RHAMMsilenced cells. protein expression levels in immunoblotting experiments are quantified by normalizing to β-actin levels. (F) In synchronized early mitotic cell, the levels of Aurora A and pAurora A were reduced in cells pretreated with siRNA targeting RHAMM compared with those treated with scrambled control siRNA. proteasome inhibition (MG132, 15 μM) was sufficient to recover the level of Aurora A, but not pAurora A, in RHAMM-silenced cells. β-actin levels confirmed equal loading. protein expression levels in immunoblotting experiments are quantified by normalizing to β-actin levels.
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Cell Cyclekinetochores and found that its depletion had no effect on cold-stable kinetochore fibers. 9 Therefore, fundamental questions remain in the literature regarding the putative contribution of RHAMM to mitotic spindle assembly, TPX2 location, and biochemical signaling through Aurora A.
Aurora A has been regarded as an important regulator for cell cycle control and mitotic progression since its initial discovery in Drosophila. 38 Accordingly, kinase activation is tightly regulated temporally and spatially by its cofactors. During G 2 , Aurora A is activated by the LIM protein Ajuba, along with Bora and PLK1 at the centrosome to promote centrosome maturation and mitotic entry. 21, 22, 33 TPX2 is the most prominent coactivator of Aurora A during mitosis. 13, 14, 23 Thus, the regulation of spatial availability of TPX2 determines local Aurora A activity and promotes mitotic spindle assembly. Here, we identify RHAMM as a new and central regulator for Aurora A activity through the modulation of TPX2 abundance and localization.
Our studies located RHAMM to sites of microtubule assembly near kinetochores in asynchronous prophase cells and during microtubule regrowth assays in mitotic cells. This localization for RHAMM was transient in asynchronous cells, and more pronounced when GFP-RHAMM was overexpressed, but restricted to mitotic stages prior to chromosome alignment. This may explain why RHAMM was not robustly immunolocalized to cold-stable kinetochore fibers in metaphase cells. 9 Our findings that RHAMM located near kinetochores are consistent with those from studies of anastral assembly in Xenopus cells 10, 11 and may help to interpret the findings for mitotic phenotypes linked to RHAMM depletion in a recent genome-wide screen. 36 Blind alignment of mitotic phenotypes that resulted from RHAMM depletion against all other mitotic phenotypes identified by Neumann and colleagues revealed substantial overlap with defined kinetochore proteins, which suggests shared functions (Fig. S1E) ; phenotypes resulting from depletion of Aurora A, RHAMM, or TPX2 also overlap (Fig. S1E) . Together, these results suggest that RHAMM influences mitotic events near to kinetochores, such as k-fiber assembly, chromosome attachment, and the successful completion of the spindle assembly checkpoint. Indeed, RHAMM, along with HURP, BARD1, and NuSAP, was targeted by the anaphasepromoting complex. 39 However, neither the correct localization of the BubR1 checkpoint protein nor the activation of the checkpoint in response to nocodazole were altered in published analyses of RHAMM-depleted cells. 9 Thus, a mechanistic role for RHAMM, if any, at kinetochores during the spindle assembly checkpoint is not currently clear.
RHAMM depletion prevented TPX2 localization at microtubule-assembly sites and augmented its proteasome-mediated proteolysis, which is likely prevented when TPX2 and Aurora A are in a complex. 26, 40 Chemical inhibition of the proteasome rescued TPX2 and Aurora A abundance but incompletely recovered Aurora A activity in RHAMM-depleted cells. Thus, kinase activity required both abundance and the correct location of TPX2, and RHAMM was a necessary regulator for these 2 interdependent processes. Insufficient k-fiber assembly perturbs kinetochore-microtubule attachment, which affects spindle length due to a lack of resistance for poleward movement exerted by microtubule motors and downstream chromosome segregation. Consistently, RHAMM depletion reduced spindle length and gave rise to compressed spindles. However, k-fiber nucleation was not eliminated with RHAMM depletion, but rather was significantly attenuated and delayed to later time points in the microtubule-regrowth assay (Video S7). Thus, RHAMM was not essential for k-fiber assembly but enhanced this process by augmenting Aurora A activity at these sites.
While we showed here that RHAMM played a positive role in the correct location of TPX2 and the activation of Aurora A during spindle assembly, we do not discount that RHAMM, or a phosphorylated variant thereof, may also competitively inhibit the localization of TPX2. It is provocative, therefore, that we found the RHAMM-binding domain in TPX2 (aa 40-319) overlaps with the primary nuclear localization signal and an essential domain (aa 284-287) for an interaction with importin-α. 28 The proximity of these binding domains suggests that RHAMM may compete with importin-α for complexes with TPX2. If so, this may help to explain why the silencing of RHAMM altered the nuclear localization of TPX2 in interphase cells, 41 while the augmentation of RHAMM, through inhibition of BRCA1, mislocalized TPX2 during anastral assembly in Xenopus cells. 11 Moreover, the minimal interaction domain for RHAMM in TPX2 (aa 40-319) also contains a KEN box, 40 which is recognized by the anaphase promoting complex/cyclosome for targeted degradation and may help to explain how the silencing of RHAMM attenuates TPX2 stability. Taken together, our data identify RHAMM as a new and central regulator for Aurora A activity; modulation of RHAMM and its subsequent influence on TPX2 location and abundance may affect Aurora A kinase activity in a cell-type and context-dependent manner.
42,43
Materials and Methods
Cell culture and cell cycle synchronization HeLa cells were purchased from ATCC and cultured in Dulbecco modified Eagle medium (DMEM, Thermo-Fisher) supplemented with 10% fetal bovine serum (Invitrogen). HeLa cells that stably express eGFP-α-Tubulin and mCherry-Histone-H2B were kindly provided (Gruneberg Lab, University of Liverpool) 44 and maintained in media with 0.3 μg/ml puromycin (Invitrogen) and 0.5 μg/ml blasticidin S (Invitrogen). RPMI 8226 cells were purchased from ATCC and cultured in ATCCformulated RPMI-1640 Medium (ATCC) supplemented with 10% fetal bovine serum (Invitrogen). All cell lines were grown at 37 °C in a 5% (v/v) CO 2 incubator. For synchronization, cells were subjected to a double thymidine block with 2 mM thymidine (Sigma) as described. TPX2(1-319) was amplified from mCherry-TPX2 (Origene), while TPX2(40-783) and TPX2(319-783) were amplified from TPX2-GFP (Origene). Products were cloned into pDONR223 and transferred into pLenti6/V5-DEST or pDEST57 expression vectors (Invitrogen). Site-directed mutagenesis was performed using the QuikChange II kit (Agilent). Primer sequences used for PCR were listed in Table S1 .
Transfection (siRNA and plasmids) On-target plus siRNA (Dharmacon) sequences are listed in Table S1 . Scrambled siRNA was used as a negative control. Transfections of siRNA and plasmid used Lipofectamine 2000 ™ (Invitrogen) following the manufacturer's protocols. Message and protein expression levels were measured 48-72 h post-transfection.
Lentivirus-mediated shRNA knockdown and generation of sub-lines
Lentivirus packaging, envelope, and control non-hairpin (NHP) pLKO.1 plasmids (Addgene) were used with shRNA against TPX2 (Sigma) as described 41 (Table S1 ). Transfected cells were selected with 0.5 μg/ml puromycin (GIBCO) for 1 wk and maintained with 0.3 μg/ml puromycin.
RT-PCR and qPCR
Total RNA was extracted from cells using RNeasy mini kit (Qiagen), quantified with NanoDrop (Thermo-Fisher), and 1 μg of total RNA was converted to cDNA using AccessQuick (VWR). qPCR reactions were run in triplicate in an 7000 series machine (Applied Biosystems). Analysis of qPCR results was done using the delta delta Ct method. Expression of RHAMM mRNA was normalized to the level of TATA box binding protein (TBP). Primers and conditions are listed in Table S1 .
Western blot and immunoprecipitation Cells were lysed at 0.5−1.0 × 10 7 cells/ml in RIPA buffer (western blot) or 0.5% NP-40 immunoprecipitation buffer (50 mM TRIS-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40) supplemented with protease inhibitors (Roche). Cell lysates were clarified by centrifugation at 16 000 × g for 10 min at 4 °C, and protein concentration was determined using the BCA protein assay kit (Pierce). For immunoprecipitation, lysates were precleared with protein A/G PLUS-Agarose beads (Santa Cruz) for 2 h at 4 °C with rotation. Protein complexes were isolated by incubation with 2.5 μg antibodies for 6 h at 4 °C with rotation, and then with protein A/G PLUS-Agarose beads for 4 h at 4 °C with rotation. Isolated complexes were washed 3 times with lysis buffer. Lysates were mixed with SDS sample buffer, separated by SDS-PAGE, and blotted with indicated primary antibodies and detected by HRP-or IRDye-conjugated antibodies and enhanced chemiluminescence (GE Healthcare) or Odyssey IR imaging (LI-COR) system, respectively.
Microtubule regrowth assay Microtubules were depolymerized by treating cells with 5 μM nocodazole (Sigma) for 1 h at 37 °C. Cells were then washed 3 times with PBS and incubated in warm fresh media at 37 °C to allow microtubule regrowth. Cells were fixed at specified time points or living cells were imaged.
Immunofluorescence and image acquisition Cells grown on coverslips were fixed with cold methanol. Cells were permeabilized with PBS-0.25% Triton X-100. Antibodies were diluted in PBS with 0.1% Triton X-100 and 3% BSA. Cells were washed 3 times in PBS-0.5% Tween-20 before and after incubations. Coverslips were mounted with ProLong Gold Antifade Reagent containing DAPI (Invitrogen).
Fixed cells were imaged using a 60× 1.2NA oil objective with the Fluoview software (Olympus) on the Olympus Fluoview FV10i (Olympus). Image stacks of 9 optical sections with a spacing of 1.0 μm through the cell volume were taken. Maximum intensity projection of the fluorescent channels was performed in ImageJ v1.46j (National Institute of Health).
For live-cell imaging, the glass coverslip was mounted in a silicone gasket (Chamlide CMM) and placed in a 37 °C and 5% CO 2 environmental chamber (Precision Control). Images were taken using a 40× 0.75 NA dry objective with the MetaMorph 7.5 software (Molecular Devices Inc) on the Olympus IX81 epifluorecent microscope (Olympus). For mitosis analysis, images were taken every 15 min using 350-ms exposures 2 × 2 binned resolution, with 2% of full lamp intensity per channel, and 7 optical sections spaced 1.0 μm apart. For microtubule regrowth analysis, images were taken every 2 min using 350-ms exposures 2 × 2 binned resolution, with 2% of full lamp intensity, and 7 optical sections spaced 1.0 μm apart. Maximum intensity projection of the fluorescent channels was performed in MetaMorph (Molecular Devices Inc).
Live imaging of the FRET (fluorescence resonance energy transfer) biosensor (kindly provided by the Lampson lab, University of Pennsylvania) 31 was performed using the Olympus IX81 epifluorescent microscope equipped with a 60× 1.35NA oil Figure 6 (See previous page) . RHAMM is required for the temporally-and spatially-regulated activity of Aurora A. (A) pAurora A specific immunoflourescence at the spindle poles (regions of interest identified by tUBG1) was significantly reduced in cells treated with MLN8237 (Aurora A specific inhibitor) or siRNA targeting RHAMM, relative to control siRNA-treated cells. Scale bars = 10 μm. (mean ± s.d., n = 3, *P < 0.05). (B) pAurora A localization to non-centrosome microtubule assembly sites was abolished in RHAMM-silenced mitotic cells during recovery from nocodazole treatment. Scale bars = 10 μm. (C) HeLa cells expressing a Hec-1 targeted pLK1 FRet sensor were imaged during recovery from nocodazole treatment. phosphorylation of the kinetochore-targeted sensor was highest in early prometaphase (0-18 min) and diminished to background levels by metaphase (18-20 min) as indicated by the YFp:tFp emission ratio. Scale bars = 10 μm. (mean ± SeM., n = 3, 6 cells per treatment). (D) Relative to measurements in cells incubated with DMSo vehicle control, FRet ratios for the Hec-1 targeted pLK1 substrate were significantly higher in cells incubated with either a pLK1-specific inhibitor (BI2536, 20 nM for 2 h) or an Aurora A-specific inhibitor (MLN8237, 1 μM for 2 h) during prometaphase (2 min after nocodazole washout). pretreatment of cells with siRNA targeting RHAMM, but not with scrambled siRNA controls, also significantly augmented the FRet emission ratio in prometaphase cells. No significant change in the FRet ratio was observed in metaphase cells (20 min after nocodazole washout) (mean ± SeM., n = 3, 6 cells per treatment, *P < 0.05).
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objective, a cooled charge coupled device camera (CoolSNAP HQ2; Photometrics) controlled by the MetaMorph 7.5 software (Molecular Devices Inc). TFP and YFP emissions were acquired simultaneously with a 505DCXR beam splitter (Dual-View; Optical Insights, LLC) with the following optical filters: 438/24 for TFP excitation; 480/30 for TFP and 535/40 for YFP emission, respectively. Images were taken every 2 min using 300-ms exposures at 2 × 2 binned resolution for 30 min after nocodazole washout, with 45% of lamp intensity (X-Cite exacte, Lumen Dynamics) and 5 optical sections spaced 1.0 μm apart. Postacquisition processing of images was performed using ImageJ v1.46j (National Institute of Health), as follows. The TFP and YFP emission images were background corrected by subtracting the value obtained from the cytoplasm, which does not include the kinetochore regions. The YFP/TFP FRET emission ratio value was then calculated as an average for the region of interest that was demarcated by the whole cell. Pseudocolored FRET images were generated by viewing the ratiometric data using the Ratio LUT (Look Up Figure 3C and D, which are mean ± standard error of mean. Statistical analysis was performed by unpaired 2-tailed Student t test. The results were considered significant at P < 0.05.
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